Rpg Life Sciences Profit & Loss Annual

Trade
BSE: 532983 | NSE: RPGLIFE | ISIN: INE105J01010 | Sector: Biotechnology & Drugs
2,180.40 -16.85 (-0.77%)Updated : 21 Apr 2025
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 582.05512.81440.16389.14
Total Revenue 582.05512.81440.16389.14
Costof Revenue Total 208.56184.52162.90148.91
Gross Profit 373.49328.29277.26240.23
Selling/ General/ Admin Expenses Total 239.43224.82187.10158.19
Depreciation/ Amortization 17.0715.5015.6616.47
Other Operating Expenses Total 5.91-3.8012.10
Total Operating Expense 470.97424.84369.46335.67
Operating Income 111.0887.9770.7053.47
Interest Inc( Exp) Net- Non- Op Total 6.75-0.312.43-0.07
Gain( Loss)on Saleof Assets 0.01-0.780.00-0.01
Net Income Before Taxes 117.8491.6873.1753.58
Provisionfor Income Taxes 30.1824.0421.6913.58
Net Income After Taxes 87.6667.6451.4840.00
Net Income Before Extra Items 87.6667.6451.4840.00
Net Income 87.6667.6451.4840.00
Income Availableto Com Excl Extra Ord 87.6667.6451.4840.00
Income Availableto Com Incl Extra Ord 87.6667.6451.4840.00
Diluted Net Income 87.6667.6451.4840.00
Diluted Weighted Average Shares 1.651.651.651.65
Diluted EPS Excluding Extra Ord Items 53.0040.9031.1324.19
DPS- Common Stock Primary Issue 16.0012.009.607.20
Diluted Normalized EPS 53.0041.2531.1324.19
period Length 12.0012.0012.0012.00
period Type ----
Other Net -4.800.040.19
Unusual Expense( Income) ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,370.00+64.15(4.91%)
828.05+33.65(4.24%)
422.80-4.45 (-1.04%)
2,350.00-24.65 (-1.04%)